Wolverine Trading
VBIV

Wolverine Trading’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Wolverine Trading’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,197
Closed -$245K – 7159
2021
Q2 		$245K Buy
2,197
+1,164
+113% +$113K ﹤0.01% 4738
2021
Q1 		$91K Buy
1,033
+393
+61% +$39.8K ﹤0.01% 5476
2020
Q4 		$58K Buy
+640
New +$54.6K ﹤0.01% 4587

Other funds holding VBIV

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wolverine Trading's VBIV Position: Q3 2021 in Review

Wolverine Trading sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2021, closing a stake of 658 shares — an estimated $73K sold.

Wolverine Trading first reported a position in VBIV in Q4 2020 and held it in 3 quarters. The position peaked at $73K in Q2 2021. 126 funds tracked by Wall St. Rank hold VBIV as of Q3 2021.

  • Wolverine Trading reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2021 after selling out during the quarter.
  • Wolverine Trading sold 658 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2021, an estimated $73K.
  • Wolverine Trading first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q4 2020 and held it in 3 quarters.
  • Wolverine Trading's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $73K in Q2 2021.
  • 126 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2021.

Based on Wolverine Trading's 13F filing for Q3 2021, filed 12 Nov 2021.